Biocon Ltd fell 2.7 per cent after its July-September earnings lagged estimates of some analyst.
The margins contracted by 90 bps to 22.8 per cent, on account of higher employee costs. Biocon said its biopharma business continues to be impacted by factors like geo-political challenges.
Biocon shares were trading down 1.22 per cent at Rs 473.90 as of 10.43 a.m.
Copyright: Thomson Reuters 2014
Get Breaking news, live coverage, and Latest News from India and around the world on NDTV.com. Catch all the Live TV action on NDTV 24x7 and NDTV India. Like us on Facebook or follow us on Twitter and Instagram for latest news and live news updates.